StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Emmaus Life Sciences's price to sales ratio was 0.2× on Oct 19, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 4.4×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.2×+0.2
2025Dec 31, 20250.0×+0.0
2024Dec 31, 20240.0×−0.2
2023Dec 29, 20230.2×−0.6
2022Dec 30, 20220.8×−2.6
2021Dec 31, 20213.5×+1.4
2020Dec 31, 20202.0×−248.9
2019Apr 30, 2019250.9×+104.0
2018Dec 31, 2018146.9×−350.1
2017Aug 31, 2017497.0×+496.9
2016Dec 30, 20160.1×−184.2
2015Dec 31, 2015184.3×+172.7
2012Oct 31, 201211.6×−33.6
2011Dec 30, 201145.2×−165.4
2010Dec 31, 2010210.6×–

More Emmaus Life Sciences figures

See a number that looks wrong?